Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Plus Therapeutics Inc. buy me8

Plus Therapeutics Inc.
Start price
€47.10
23.03.21 / 0%
Target price
€75.00
23.03.22
Performance (%)
-37.90%
End price
€29.25
03.04.21
Summary
This prediction ended on 03.04.21 with a price of €29.25. The BUY prediction by me8 for Plus Therapeutics Inc. performed very badly with a performance of -37.90%. This prediction was marked as speculative and is excluded from me8's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y 3y
Plus Therapeutics Inc. 17.410% 17.410% -15.000% -94.125%
iShares Core DAX® 1.454% 0.904% 16.592% 16.557%
iShares Nasdaq 100 -0.913% 3.463% 36.062% 50.205%
iShares Nikkei 225® 2.355% 3.830% 14.881% 10.110%
iShares S&P 500 0.283% 2.639% 29.599% 44.509%

According to me8 what are the pros and cons of Plus Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Capable Management
Some uniques
Cons
Bad culture

Comments by me8 for this prediction

In the thread Plus Therapeutics Inc. diskutieren

Buy Plus Therapeutics Inc.

me8 
0
Report Share
23.03.21 Buy -37.90%
Prediction Buy
Perf. (%) -37.90%
Target price 5.000
Change
Ends at 23.03.22

Kursziel gesetzt auf 5,0

me8 
0
Report Share
23.03.21
In the thread Trading Plus Therapeutics Inc.
Prediction Buy
Perf. (%) -37.90%
Target price 5.000
Change
Ends at 23.03.22

Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.

me8 
0
Report Share
03.04.21